MacuLogix Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 52

Employees

  • Latest Deal Type
  • M&A

MacuLogix General Information

Description

Developer of optical testing equipment designed to increase early detection of age-related macular degeneration. The company's testing equipment uses a dark adaptometer that engages in the detection of progressive eye diseases that lead to macular degeneration, enabling eye care specialists to intervene as early as possible and maintain a patient's quality of life with proactive intervention.

Contact Information

Formerly Known As
Apeliotus Vision Science
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 1000 Kreider Drive
  • Suite 700
  • Middletown, PA 17057
  • United States
Primary Industry
Diagnostic Equipment
Acquirer
Vertical(s)
Corporate Office
  • 1000 Kreider Drive
  • Suite 700
  • Middletown, PA 17057
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MacuLogix Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Merger/Acquisition 26-Jul-2022 Completed Generating Revenue
11. Debt - General 04-Apr-2022 Completed Generating Revenue
10. Later Stage VC (Series E) 14-Dec-2021 Completed Generating Revenue
9. Later Stage VC (Series E) 10-Nov-2020 Completed Generating Revenue
8. Debt - PPP 12-Apr-2020 Completed Generating Revenue
7. Later Stage VC (Series D) 04-Mar-2019 Completed Generating Revenue
6. Debt - General 20-Jul-2018 Completed Generating Revenue
5. Later Stage VC (Series C) 31-Jul-2015 Completed Generating Revenue
4. Later Stage VC (Series B) 05-Jun-2014 $3.6M $10.1M Completed Generating Revenue
3. Later Stage VC (Series A) 11-Mar-2013 $3.6M $6.5M Completed Generating Revenue
To view MacuLogix’s complete valuation and funding history, request access »

MacuLogix Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series E
Series D
Series C
Series B 2,056,838 $0.000100 8% $1.98 $1.98 1x $1.98 3.32%
Series A 1,690,198 $0.000100 8% $2.32 $2.32 1x $2.32 2.73%
To view MacuLogix’s complete cap table history, request access »

MacuLogix Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of optical testing equipment designed to increase early detection of age-related macular degeneration. The com
Diagnostic Equipment
Middletown, PA
52 As of 2022

Woodland Hills, CA
 

Coralville, IA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MacuLogix Competitors (2)

One of MacuLogix’s 2 competitors is Eyenuk, a Venture Capital-Backed company based in Woodland Hills, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Eyenuk Venture Capital-Backed Woodland Hills, CA
Digital Diagnostics Venture Capital-Backed Coralville, IA
You’re viewing 2 of 2 competitors. Get the full list »

MacuLogix Patents

MacuLogix Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-201441-S Headset for ocular testing and measurement Active 23-Mar-2020
CA-203296-S Opthamlic testing device with animated graphical user interface Active 23-Mar-2020
CA-198684-S Light-proof seal cover for an ocular testing system Active 21-Sep-2019
CA-201440-S Head-wearable device for ocular testing and measurement Active 21-Sep-2019
CA-198964-S Light-proof seal for an ocular testing headset Active 21-Sep-2019
To view MacuLogix’s complete patent history, request access »

MacuLogix Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MacuLogix Former Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
ATEL Capital Group Asset Manager Minority
Ben Franklin Technology Partners of Northeastern Pennsylvania Venture Capital Minority
Berwind Private Equity Family Office Minority
Fisk Ventures Family Office Minority
Horizon Technology Finance BDC Business Development Company Minority
You’re viewing 5 of 10 investors. Get the full list »

MacuLogix FAQs

  • When was MacuLogix founded?

    MacuLogix was founded in 2004.

  • Where is MacuLogix headquartered?

    MacuLogix is headquartered in Middletown, PA.

  • What is the size of MacuLogix?

    MacuLogix has 52 total employees.

  • What industry is MacuLogix in?

    MacuLogix’s primary industry is Diagnostic Equipment.

  • Is MacuLogix a private or public company?

    MacuLogix is a Private company.

  • What is MacuLogix’s current revenue?

    The current revenue for MacuLogix is .

  • How much funding has MacuLogix raised over time?

    MacuLogix has raised $102M.

  • Who are MacuLogix’s investors?

    ATEL Capital Group, Ben Franklin Technology Partners of Northeastern Pennsylvania, Berwind Private Equity, Fisk Ventures, and Horizon Technology Finance BDC are 5 of 10 investors who have invested in MacuLogix.

  • Who are MacuLogix’s competitors?

    Eyenuk and Digital Diagnostics are competitors of MacuLogix.

  • When was MacuLogix acquired?

    MacuLogix was acquired on 26-Jul-2022.

  • Who acquired MacuLogix?

    MacuLogix was acquired by LumiThera.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »